Abstract:The relevant laws and regulations of drug clinical trials were introduced in this paper. It is pointed out that with drug re-gulatory laws and technological advances, clinical trials have become an important link in the development of new drugs of traditional Chinese medicines(TCM). Clinical trials of new drugs of TCM must comply with the requirement of "Good Clinical Practice for Trial on Medicinal Products". In view of the particularities of clinical trials of new drugs of TCM, China has established an ethical review system for clinical research in TCM and carried out ethical review and certification of TCM research. In order to guide the development of clinical trials of new drugs of TCM, relevant departments have promulgated a series of guidelines for clinical trials of it, and established a new review system and technical requirements for clinical trials. Since 1983, the "national clinical pharmacology base" has been established. At present, there are 96 drug clinical trial institutions and 32 phase I clinical research wards in TCM hospitals, which can meet the development of clinical trials of new drugs of TCM. In the long-term practice, the technical team has continued to grow and develop, the research experience and technical strength have been significantly improved, and a large number of experts have become the backbone of clinical research in Chinese medicine. It is pointed out that we should attach importance to risk and benefit assessment, human experience, select scientific, objective and appropriate effectiveness indexes, evaluate the efficacy of TCM syndromes, and encourage the use of electronic methods in clinical research of new drugs of TCM. Based on the analysis of clinical trials of TCM in recent five years, it is pointed out that the active degree of clinical trials of new drugs of TCM is not high, the innovation ability of it is insufficient and the ability and enthusiasm of all aspects need to be improved. It is of great significance to carry out clinical trials of new traditional Chinese medicines to upgrade the TCM industry and produce high-level evidence-based medicine evidences. The high quality development of TCM can be promoted by strengthening clinical trials of new drugs of TCM.

Consideration of exposure-response relationships during clinical trials of new drugs

Protection of Human Rights in Clinical Trials

Statistical Considerations on Drug Safety in Clinical Trials

Comparison and reflection of several exploratory clinical trial approaches

Discussions on the standardized safety evaluation of new drugs in phase I clinical trials

Consideration on Nonclinical Evaluation for the Conduct of Human Clinical Trails and Marketing Authorization for New Anticancer Drugs

From Bench to Bedside: A Review of Clinical Trials in Drug Discovery and Development

Some Thoughts on the Construction of Chemical Drug Evaluation System

Incorporating Historical Information to Improve Phase I Clinical Trials

Statistical Considerations in Design of Clinical Trial for Fixed Dose Drug Combination

Development and Problems of Medical Ethics in Clinical Drug Trials

Some Statistical Issues of Confirming Efficacy in Clinical Trials

[Development of clinical trial of new drugs of traditional Chinese medicines]

Main principles of designing clinical trial of drugs

Current trends of nonclinical safety evaluation for new drugs

Thinking on Ethics and Science Principle in Clinical Drug Trials

On the Ethical Problem in Drug Clinical Trials

Review of current controversial issues in clinical trials

Discussion on management of new drug clinical trials proj'ect

An Instrumental Variable Approach to Learning the Causal Exposure-Response Relationship in a Randomized Dose Comparison Trial

[Phase 0 Clinical Trials and Post-Marketed Re-Evaluation of Clinical Safety in Injection of Traditional Chinese Medicine].